tiprankstipranks
Protara Therapeutics, Inc. (TARA)
NASDAQ:TARA
US Market
TARA
Protara Therapeutics
RESEARCH TOOLSreports

Protara Therapeutics (TARA) Income Statement

1,386 Followers

Protara Therapeutics Income Statement

Last quarter (Q4 2025), Protara Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Protara Therapeutics's net income was $-17.31M. See Protara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -362.00K$ 0.00$ -341.00K$ 0.00$ 0.00
Operating Expenses
$ 64.19M$ 49.15M$ 43.27M$ 67.06M$ 47.49M
Depreciation and Amortization
$ 362.00K$ 332.00K$ 341.00K$ 248.00K$ 117.00K
EBITDA
$ -64.19M$ -48.82M$ -43.27M$ -64.57M$ -45.40M
Operating Income
$ -64.55M$ -49.15M$ -43.61M$ -67.06M$ -47.49M
Other Income/Expenses
$ 7.11M$ 4.56M$ 3.19M$ 1.11M$ 237.00K
Pretax Income
$ -57.44M$ -44.60M$ -40.42M$ -65.95M$ -47.25M
Net Income
$ -57.44M$ -44.60M$ -40.42M$ -65.95M$ -47.25M
Per Share Metrics
Basic EPS
$ -1.34$ -2.17$ -3.57$ -5.86$ -4.20
Diluted EPS
$ -1.34$ -2.17$ -3.57$ -5.86$ -4.20
Weighted Average Shares Outstanding
 42.84M 20.59M 11.33M 11.26M 11.23M
Weighted Average Shares Outstanding (Diluted)
 42.84M 20.59M 11.33M 11.26M 11.23M
Currency in USD

Protara Therapeutics Earnings and Revenue History